Protein kinase B (also known as AKT) and the mechanistic target of rapamycin (mTOR) are central regulators of T cell differentiation, proliferation, metabolism, and survival. Here, we show that during chronic murine lymphocytic choriomeningitis virus infection, activation of AKT and mTOR are impaired in antiviral cytotoxic T lymphocytes (CTLs), resulting in enhanced activity of the transcription factor FoxO1. Blockade of inhibitory receptor programmed cell death protein 1 (PD-1) in vivo increased mTOR activity in virus-specific CTLs, and its therapeutic effects were abrogated by the mTOR inhibitor rapamycin. FoxO1 functioned as a transcriptional activator of PD-1 that promoted the differentiation of terminally exhausted CTLs. Importantly, FoxO1-null CTLs failed to persist and control chronic viral infection. Collectively, this study shows that CTLs adapt to persistent infection through a positive feedback pathway (PD-1/FoxO1/PD-1) that functions to both desensitize virus-specific CTLs to antigen and support their survival during chronic viral infection.
INTRODUCTION
Chronic viral infection is a global health concern contributing to millions of deaths annually (Virgin et al., 2009) . Viruses that cause chronic infection have evolved strategies to evade immune responses. The persistence of antigen can lead to alterations in cytotoxic T lymphocyte (CTL) proliferation, survival, effector functions, and gene expression that lead to the differentiation of dysfunctional or ''exhausted'' CTLs (Wherry, 2011) . Exhausted CTLs that arise during certain chronic infections and cancers are characterized by impaired production of interferon-g (IFN-g), tumor necrosis factor-a (TNF-a), and interleukin-2 (IL-2), reduced cytotoxicity, and elevated surface expression of a number of inhibitory receptors, most notably programmed cell death protein 1 (PD-1) (Baitsch et al., 2011; Barber et al., 2006; Wherry, 2011) . Upon interaction with its ligands PD-L1 or PD-L2, PD-1 can inhibit proximal T cell antigen receptor (TCR) signaling and suppress CTL function (Chemnitz et al., 2004; Keir et al., 2008; Mueller et al., 2010; Parry et al., 2005; Wei et al., 2013; Yokosuka et al., 2012; Zinselmeyer et al., 2013) . Importantly, the induction of PD-1 and CTL exhaustion during chronic viral infection helps to balance the benefits of antiviral responses and viral control with the costs of immunopathology to the host (Barber et al., 2006; Frebel et al., 2012; Mueller et al., 2010; Zinselmeyer et al., 2013) .
Evidence strongly points to a central role for sustained TCR signaling in fine-tuning the expression of PD-1 and many other genes that affect the function and homeostasis of virus-specific CTLs during chronic viral infection (Kao et al., 2011; Keir et al., 2008; Paley et al., 2012; Riley, 2009; Shin et al., 2007 Shin et al., , 2009 . However, it is unclear how TCR signaling is integrated with transcriptional changes that regulate these processes in CTLs during chronic infection. The activation of phosphoinositide 3-kinase (PI3K), protein kinase B (also known as AKT), and the mechanistic target of rapamycin (mTOR) either as part of mTOR complex 1, mTORC1, or mTORC2 by T cell, cytokine, and costimulatory receptors are of particular interest because they function in parallel pathways to control many aspects of T cell differentiation, proliferation, function, and survival Michalek and Rathmell, 2010; Pearce and Pearce, 2013; Powell and Delgoffe, 2010; Rao et al., 2010) . Additionally, activation of PI3K, AKT, and mTOR signaling can induce a metabolic switch toward anabolic metabolism and aerobic glycolysis in activated CD8 + T cells that is transcriptionally coordinated in part by c-myc and hypoxia inducible factor-1 (HIF-1) Finlay et al., 2012; Frauwirth et al., 2002; Jacobs et al., 2008; Macintyre et al., 2011; Wang et al., 2011) . PI3K, AKT, and mTOR activation can also enhance T-bet transcription factor expression and the expression of several effector molecules including IFN-g and granzyme B (Macintyre et al., 2011; Rao et al., 2010; Tomasoni et al., 2011) . Ligation of the inhibitory receptor PD-1 on the surface of activated CTLs results in enhanced expression and/or recruitment of SHP-1, SHP-2, or PTEN phosphatases that dampens proximal TCR signaling and activation of AKT (Patsoukis et al., 2013; Riley, 2009; Yokosuka et al., 2012; Zinselmeyer et al., 2013) . Importantly, blockade of PD-1:PD-L1 interactions promotes the expansion of antiviral CTLs and improves viral control during viral infection (Barber et al., 2006) . These findings have made PD-1 a prime therapeutic target for enhancing T cell responses during certain forms of chronic infection and cancer (Speiser et al., 2014) . However, the pertinent signaling pathways that underlie the recovery of T cell responses by PD-1:PD-L1 blockade in vivo are not known; such information could offer important insights into the etiology of CTL exhaustion and might also provide a basis for the development of therapies for treating chronic diseases.
Although signaling through PI3K, AKT, and mTOR enhances effector CTL differentiation, it suppresses the differentiation and maturation of memory CTLs (Araki et al., 2009; Hand et al., 2010; Kim et al., 2012; Pearce et al., 2009; Rao et al., 2010) . This occurs, in part, because AKT phosphorylation inhibits the nuclear activity of FoxO transcription factors, namely FoxO1, which positively regulates several genes involved in naive and memory T cell survival and trafficking including Il7ra, Ccr7, Klf2, Sell (CD62L), Tcf7, Eomes, and Bcl2 (Kerdiles et al., 2009 (Kerdiles et al., , 2010 Kim et al., 2012 Kim et al., , 2013 Hess Michelini et al., 2013; Ouyang et al., 2009 Ouyang et al., , 2010 Ouyang et al., , 2012 Rao et al., 2012; Sullivan et al., 2012a Sullivan et al., , 2012b Tejera et al., 2013) . Moreover, FoxO1 counterbalances effector CTL differentiation via repression of T-bet, IFN-g, and granzyme B expression (Hess Michelini et al., 2013; Ouyang et al., 2012; Rao et al., 2012) . However, the precise roles of FoxO1, AKT, and mTOR signaling in controlling functional exhaustion, metabolism, and differentiation of CD8 + T cells during chronic infection has not been explored.
In this study, we identified critical roles for PI3K, AKT, and mTOR signaling and FoxO1 transcriptional activity in the homeostasis and differentiation of CD8 + T cells during chronic lymphocytic choriomeningitis virus (LCMV) infection. We found that sustained antigenic signaling from persisting virus reduced, rather than enhanced, TCR signal transduction and activation of AKT and mTOR. This suppression of mTOR activation was largely due to PD-1:PD-L1 signaling, and rapamycin abolished the restoration of CTL responses and overall therapeutic efficacy of a-PD-L1 blockade. Consequently, suppression of AKT led to increased FoxO1 nuclear activity, which was necessary to sustain PD-1 expression and acquisition of terminally exhausted states during chronic infection. However, FoxO1 was also required for Bcl2 expression and the survival of CTLs during chronic infection. These results suggested that increased FoxO1 activity and expression of PD-1 are important adaptations by virus-specific CTLs during persistent infection that support their homeostasis.
RESULTS
TCR Activation of PI3K, AKT, and mTOR and Markers of Anabolic Metabolism Are Poorly Sustained in Exhausted CD8 + T Cells
To better understand the regulation of PI3K, AKT, and mTOR signaling in antigen-specific CTLs during acute (LCMV-Arm) and chronic (LCMV-Cl13) viral infection, we combined adoptive T cell transfer techniques and phospho-flow cytometry (Figure 1A) . Although peak phosphorylation of S6, a readout of mTOR activity (present at day 5 postinfection [p.i.]), was reduced in CTLs during LCMV-Cl13 compared to LCMV-Arm infection, p-S6 was not sustained in CTLs during LCMV-Cl13 infection despite the persistence of virus ( Figure 1B ; Sullivan et al., 2012b) . These data led us to hypothesize that CTLs during chronic infection might be impaired in their ability to sustain the phosphorylation of PI3K, AKT, and mTOR, and that this might contribute to their functional exhaustion.
To address this possibility, we directly compared the TCR signaling capacity between two populations of gp33-41-specific TCR transgenic (P14) CTLs isolated from LCMV-Arm or LCMV-Cl13 infection. By 8 days p.i., CTLs from LCMV-Cl13 infection demonstrated a loss in TCR responsiveness compared to those from LCMV-Arm infection as measured by reduced phosphorylation of both proximal (e.g., Zap70 (Powell et al., 2012) . Next, to determine whether the reduction in PI3K, AKT, and mTOR kinase activity in CTLs during chronic infection was a general feature associated with CTL exhaustion, we examined the ability of CTLs from acute and chronic viral infections to respond to cytokine stimulation. Although we found that the ability of CTLs from LCMV-Cl13-infected mice to phosphorylate STAT5 and STAT3 transcription factors downstream of IL-2, IL-15, and IL-21 was not significantly impaired relative to CTLs from LCMV-Arm-infected mice, their ability to activate the AKT and mTOR was ( Figures S1D-S1F ). Taken together, these results demonstrate that the progressive loss of effector functions that occurs in CTLs during chronic LCMV infection (Wherry, 2011) correlates with their impaired ability to activate the PI3K, AKT, and mTOR signaling pathways.
Chronic antigen stimulation contributes to many of the phenotypic and molecular changes that define exhausted CTLs during chronic infection Brooks et al., 2006; Kao et al., 2011; Paley et al., 2012; Shin et al., 2007) . Therefore, to directly test whether persistent antigen contributed to TCR desensitization in virus-specific CD8 + T cells during chronic viral infection, we varied the duration of antigen exposure by transferring functional P14 CTLs from acute LCMV-Arm-infected animals into recipients infected 8 days previously with either (1) LCMVArm, (2) LCMV-Cl13, or (3) LCMV-Cl13-V35A, a mutant strain of LCMV-Cl13 that contains an amino acid substitution in the gp33 epitope and is not recognized by the P14 TCR (Puglielli et al., 2001) . Importantly, infection with LCMV-Cl13-V35A resulted in comparable viremia and elevated PD-1 expression on gp276-and 396-specific CTLs (data not shown; Shin et al., 2007) . Indeed, TCR-dependent phosphorylation of S6, FoxO1/ 3a, and ERK was elevated in P14 CTLs engrafted into 
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The Regulation of CD8 + T Cell Exhaustion by FoxO1 LCMV-Arm-or LCMV-Cl13-V35A-as compared to LCMV-Cl13-infected mice ( Figure 1E ). These findings demonstrate that prolonged contact with antigen underlies the loss in TCR responsiveness and downstream signaling in CTLs during chronic infection. Consistent with their inability to sustain robust mTOR activity ( Figure 1B ), at day 21 p.i., virus-specific CTLs from chronic LCMV-Cl13 infection were unable to maintain properties of anabolic metabolism such as robust glucose uptake (2-NBDG) and expression of CD71 (transferrin receptor) and CD98 (amino acid transporter) ( Figure 2A ; Finlay and Cantrell, 2011; Finlay et al., 2009) . Furthermore, although CTLs from acute infection were able to upregulate CD71 and CD98 and initiate blastogenesis in response to TCR restimulation in a PI3K-, AKT-, and mTOR-dependent manner, CTLs from LCMV-Cl13 failed to do so (Figures 2B and S2A) . Although glucose uptake was somewhat higher at day 8 in CTLs from chronic relative to acute infection, their baseline extracellular acidification rates (ECAR, a measure of glycolysis) were similar ( Figure S2B ). Additionally, CTLs from chronic infection were less efficient in their ability to engage glycolysis when mitochondrial ATP synthesis was blocked by oligomycin ( Figure 2C ; van der . Similarly, at day 8 p.i., despite an increase in mitochondrial mass in CTLs from chronic infection ( Figure 2D ), their baseline oxygen consumption rates (OCR, a measure of mitochondrial oxidative phosphorylation) were comparable to CTLs from acute infection ( Figure S2B ). Moreover, when CTLs from chronic infection were treated with the mitochondrial uncoupling reagent FCCP, their maximal mitochondrial respiration (i.e., spare respiratory capacity [SRC]) was reduced compared to those from acute infection ( Figure 2E ; van der . Collectively, these data suggest that exhausted CTLs display deficiencies in both glycolytic and oxidative metabolism, which further underscore the decline in TCR-dependent PI3K signaling in virus-specific CTLs during chronic LCMV-Cl13 infection.
TIME %ECAR (mpH/min)
Therapeutic PD-L1 Blockade Requires mTOR Activation PD-1 is markedly upregulated on exhausted CTLs and can inhibit proximal TCR signaling and distal AKT, mTOR, S6, and ERK phosphorylation (Francisco et al., 2009; Parry et al., 2005; Sheppard et al., 2004; Yokosuka et al., 2012) . Moreover, blocking (D) Cumulative bar graphs showing the mean fluorescence intensity (MFI) of phospho-flow data from (C). (E) P14 CTLs from day 8 LCMV-Arm infection were transferred into infection-matched LCMV-Arm (white), LCMV-Cl13 (black), or LCMV-Cl13-V35A (gray) recipients. At day 15 (7 days after transfer), P14
+ CTLs were stimulated with gp33 peptide for 60 min and p-S6, p-FoxO1/3a, and p-ERK were measured by phospho-flow. Data are representative of three independent experiments that included three to five mice/group. Error bars are mean ± SEM. See also Figure S1 .
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The Regulation of CD8 + T Cell Exhaustion by FoxO1
PD-1:PD-L1 interactions can restore TCR signaling (Fife et al., 2009; Zinselmeyer et al., 2013) and boost antiviral T cell responses and viral control during LCMV-Cl13 infection (Barber et al., 2006) . First, we confirmed the ability of PD-1 to suppress mTORC1 activity (based on p-S6 staining) in virus-specific CTLs after TCR stimulation ( Figure 3A) . Next, to examine whether PD-1 suppression of mTOR activity was relevant in antiviral CTLs in vivo, LCMV-Cl13-infected mice were treated with a blocking a-PD-L1 mAb, either with or without the mTORC inhibitor rapamycin. Anti-PD-L1 mAb treatment augmented the amounts of p-S6 235/236 , CD98, CD71, and glucose uptake in CTLs (Figures 3B and 3C ; Finlay et al., 2009) . The increase in mTOR activity was accompanied by a marked increase in the frequency and number of IFN-g-and granzyme B 
(GzmB)-producing virus-specific CTLs and decrease in viral load ( Figures 3D-3G ). Importantly, rapamycin abrogated the beneficial effects of a-PD-L1 blockade on viral control and virus-specific T cell responses, including the aforementioned markers of anabolic metabolism ( Figures 3B-3F ). Taken together, these data demonstrate that PD-1 suppression of the mTOR pathway contributes to CTL exhaustion in vivo and that recovery of mTOR activity is a part of the therapeutic effects of a-PD-L1 during chronic LCMV-Cl13 infection.
Expression and Nuclear Retention of the Transcription Factor FoxO1 Is Enhanced in Exhausted CD8 + T Cells
FoxO1 supports the differentiation of regulatory T cells, suppresses effector functions, and promotes the differentiation and survival of long-lived memory CD8 + T cells (Hedrick et al., 2012; Kim et al., 2013; Hess Michelini et al., 2013; Ouyang et al., 2012; Tejera et al., 2013) . FoxO transcription factors are phosphorylated and inhibited by AKT in response to mTORC2 activation (Biggs et al., 1999; Brunet et al., 1999; Calnan and Brunet, 2008; Rao et al., 2012) . Therefore, we questioned whether the suppression of AKT signaling in CTLs during chronic viral infection results in enhanced FoxO1 activity. Consistent with decreased p-FoxO1/3a after TCR stimulation (Figures 1  and S1C -Cl13-V35A confirmed that FoxO1 expression was upregulated in an antigen-dependent manner during chronic viral infection ( Figure 4D ). Furthermore, PD-1 ligation on the surface of effector CTLs (as in Figure 3A ) could also effectively suppress the phosphorylation of FoxO1/3a in response to TCR stimulation (data not shown). These data suggest that persistent antigenic stimulation and PD-1 signaling dampens TCR-dependent activation of AKT and mTORC2, leading to enhanced nuclear accumulation of FoxO1 in antiviral CTLs during chronic infection.
FoxO1 Regulates the Homeostasis of Virus-Specific CD8 + T Cells during Chronic Viral Infection
To determine whether FoxO1 played a role in CTL exhaustion during chronic infection, we conditionally deleted Foxo1 from virus-specific CD8 + T cells during LCMV-Cl13 infection by using 5B , and S3A). Cytokine production by FoxO1 fl/fl CTLs was only modestly affected, but the expression of granzyme B, a FoxO1-repressed target gene (Macintyre et al., 2011; Hess Michelini et al., 2013; Rao et al., 2012; Tejera et al., 2013) , was markedly increased ( Figures  5C, 5D , and S3B). Despite this, viral loads remained significantly higher in FoxO1 fl/fl relative to FoxO1 +/+ mice, probably owing to a combination of decreased proliferation and survival of LCMVspecific CTLs in the absence of FoxO1 as suggested by Ki67 and by the ratio of Bim to Bcl-2 staining, respectively (Figures 5E-5G and S3C; Kim et al., 2013; Tejera et al., 2013) . Taken together, these data propose an intriguing model wherein the suppression of mTOR and AKT, and resulting increase in
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FoxO1 activity, dampens effector molecule expression but simultaneously promotes virus-specific CTL survival during chronic infection.
FoxO1 Is Necessary for the Differentiation of PD-1 hi Eomes hi Terminally Exhausted CTLs
During chronic LCMV infection, the CTL pool is maintained by periodic proliferation and conversion of PD-1 int T-bet hi / PD-1 hi Eomes hi cells (Kao et al., 2011; Paley et al., 2012) . Together these subsets cooperate to maintain a durable and partially effective CD8 + T cell response during chronic infection . Upon further inspection, we found that FoxO1 expression was increased in PD-1 hi CTLs that also expressed higher amounts of Eomes, but lower amounts of T-bet ( but no significant differences in PD-1 and T-bet expression were observed ( Figure S4B ). These data suggest that the dependency on FoxO1 for elevating Eomes, Bcl-2, and PD-1 and for repressing T-bet expression increases as chronic infection progresses. Probably, the improper regulation of these genes in FoxO1 fl/fl cells impairs CTL maintenance over time (Figures 6F-6H ; Kao et al., 2011; Paley et al., 2012; Rao et al., 2012) .
FoxO1 Binds to and Promotes the Expression of PD-1 in CD8 + T Cells Based on the decreased PD-1 expression in FoxO1
fl/fl CD8 + T cells, we hypothesized that, in addition to Eomes (Rao et al., 2012) , FoxO1 might also directly control PD-1 (Pdcd1 gene) transcription as CTLs transition from PD-1 int to PD-1 hi states during chronic LCMV infection. Examination of this possibility revealed that the upstream regulatory region of Pdcd1, named the PD-1 ''C-region'' that is trans-activated by the transcription factor NFATc1 (Oestreich et al., 2008) , also contains a putative FoxO1 binding site ( Figure 7A ; Ouyang et al., 2012) . The C-region also contains a candidate T-bet binding site and neighboring Blimp-1 binding site, and overexpression of T-bet or Blimp-1 can suppress PD-1 expression (Kao et al., 2011; Lu et al., 2014) . By chromatin immunoprecipitation (ChIP), we observed FoxO1 binding to the C-region, but not the neighboring B-region in Pdcd1 in in vitro activated CD8 + T cells (Figure 7B) . Furthermore, overexpression of FoxO1 was sufficient to enhance the activity of a Pdcd1 promoter luciferase reporter in Jurkat cells when both B-and C-regions were intact, but not when only the B-region was present ( Figure 7C ). In vitro, PD-1 expression in CD8 + T cells could be enhanced via treatments that increase FoxO1 activity such as inhibition of PI3K, AKT, or mTOR, or through inhibition of glycolysis with 2-deoxy-Dglucose (2-DG) (data not shown; Chang et al., 2013) . To test the role of FoxO1 more directly, we overexpressed an
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AKT-mediated phosphorylation-resistant mutant of FoxO1, FoxO1 AAA , in CTLs in vitro or in vivo during chronic LCMVCl13 infection. In vitro, constitutively active FoxO1
AAA was able to upregulate PD-1 expression, an effect that was enhanced further by antigenic restimulation (data not shown). In vivo, FoxO1 AAA was sufficient to augment the expression of PD-1, Eomes, and Bcl-2 while suppressing that of T-bet, effectively shifting the balance toward the differentiation of PD-1 
DISCUSSION
This study identifies the relevance of fine-tuning of the PI3K, AKT, and mTOR signaling pathways in regulating the differentiation and function of virus-specific CD8 + T cells during chronic viral infection. Our work has characterized the decline in TCR signaling in exhausted CTLs that results in reduced mTORC1 and mTORC2 activity and inability to sustain high rates of aerobic glycolysis and anabolic metabolism. Reactivation of mTOR was necessary to bolster antiviral CTL proliferation and effector functions during PD-L1 blockade therapy, thereby placing mTOR on a central axis controlling CTL exhaustion. Importantly, , n = 10-17). Error bars are mean ± SEM. See also Figure S4 .
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we identified FoxO1 as a critical rheostat downstream of mTORC2 that controls the expression of PD-1 and Bcl-2 and the balance between Eomes hi and T-bet hi CTL populations to maintain the overall homeostasis of virus-specific CTLs during chronic viral infection. These data support the notion that suppression of AKT and mTOR and augmentation of PD-1 expression via increased FoxO1 is both a normal and necessary part of the progression of CTL exhaustion that serves not only to prevent excessive immunopathology, but also to sustain virus-specific CTLs during persistent antigenic stimulation. Our study, along with that of Sullivan et al. (2012b) , also brings to light the nonredundant and apparent contrasting roles of FoxO1 and FoxO3a in regulating CTL responses during chronic infection. Although the phospho-flow analysis was unable to distinguish between phosphorylated FoxO1 and FoxO3a, other data using FoxO1-specific antibodies clearly demonstrated the enhanced expression and nuclear retention of FoxO1 protein in PD-1 hi CTLs; the specific phosphorylation state and nuclear localization of FoxO3a remains to be investigated. Additionally, whereas FoxO1 was necessary to maintain Bcl-2 expression and CTL survival, FoxO3a promoted Bim expression and CTL apoptosis during chronic LCMV infection (Grayson et al., 2006; Sullivan et al., 2012b) . Furthermore, FoxO3a does not appear to share the same role as FoxO1 in promoting the differentiation of more terminally exhausted PD-1 hi Eomes hi CTLs (Sullivan et al., 2012b) . These findings suggest that FoxO1 and FoxO3a can regulate both overlapping and divergent aspects of CD8 + T cell biology, an idea that is further supported by pathway analysis of predicted FoxO1 and FoxO3a target genes in CTLs after acute and chronic viral infection (data not shown). Additionally, this work highlights important dichotomies in the transcriptional targets of FoxO1 in CD8 + T cells between acute and chronic infection. For example, FoxO1 controls expression of Il7r, Ccr7, Sell (CD62L), and Tcf7 in long-lived memory CTLs Hess Michelini et al., 2013; Rao et al., 2012; Tejera et al., 2013) that are downregulated in exhausted CTLs during chronic infection. Similar observations have been made with regard to the transcriptional targets of T-bet and Eomes in CTLs from acute versus chronic LCMV infection (Doering et al., 2012) . These data underscore the potential role for distinct epigenetic changes and/or unique transcriptional networks in regulating how these and other transcription factors might have altered functions in the context of a resolving versus a persistent infection. In the future, it will be important to determine the transcriptional program and target genes regulated by FoxO1 and FoxO3a and how and why these might vary in the different settings of acute and chronic infection. Importantly, this study outlines a positive-feedback pathway regulating the differentiation and homeostasis of exhausted CTLs during chronic infection, wherein decaying TCR responsiveness, mediated in part by PD-1, lowered PI3K, AKT, and mTOR signaling. HIF-1 is an important downstream target of mTORC1 and thus our work provides greater understanding of why constitutive HIF-1 activity would sustain aerobic glycolysis and effector functions in CTLs during chronic LCMV infection . Further, our work identifies that decreased mTORC2 activity consequently led to elevated FoxO1 activity, which repressed GzmB but sustained PD-1, Eomes, and Bcl2 expression. Thus, FoxO1 aids in the formation and maintenance of more terminally exhausted CD8 + T cells.
Identification of FoxO1 as a transcriptional activator of Pdcd1 (PD-1) is an important finding because little is known about the regulation of this locus. Although our data show that FoxO1 can directly bind to a known regulatory element of Pdcd1 and that FoxO1 AAA can promote the differentiation of PD-1 hi CTLs during chronic LCMV infection, it is likely that the drop in PD-1 expression in FoxO1 fl/fl CTLs depends in part on increased T-bet expression because T-bet can repress Pdcd1 transcription (Kao et al., 2011; Lu et al., 2014; Hess Michelini et al., 2013; Paley et al., 2012) . Although FoxO1 has not yet been found to bind to the Tbx21 (T-bet) locus directly (Rao et al., 2012) , T-bet expression and activity are, nevertheless, markedly increased in the absence of FoxO1 (Hess Michelini et al., 2013; Rao et al., 2012; Tejera et al., 2013) . During chronic infection, it is plausible that FoxO1 and T-bet inhibit each other's binding in the C region of the Pdcd1 locus, thereby imposing divergent effects on PD-1 expression and CTL exhaustion. Alternatively, given the density of NFAT binding sites in the Pdcd1 locus, FoxO1 might cooperate with NFAT to regulate and/or sustain the expression of PD-1 in the presence of persistent antigen during chronic infection (Lu et al., 2014; Oestreich et al., 2008) . This idea is similar to the role proposed for NFAT:FoxO1 complexes that coordinate the expression and activity of FoxP3 during CD4 + regulatory T cell differentiation (Samstein et al., 2012) . We favor a model in which NFAT activity initiates PD-1 expression, whereas FoxO1 might help to sustain its expression directly and indirectly through its ability to regulate or compete with T-bet. Together, these data outline a unique transcription factor network that might regulate the expression of PD-1 and the differentiation of exhausted CTLs (Doering et al., 2012) . The FoxO family of transcription factors have a plethora of binding partners and can undergo numerous posttranslational modifications (Calnan and Brunet, 2008) . In response to nutrient deprivation, phosphorylation of FoxO transcription factors by AMPK on residues distinct from that of AKT redirects its transcriptional activity to different targets (Greer and Brunet, 2005; Greer et al., 2007) . Additionally, acetylation of FoxO1 by CBP and its deacetylation by Sirt1 can also regulate its activity and specificity, the latter being suggestive of FoxO1's role in regulating mitochondrial function and lipid oxidation (Gross et al., 2008) . Indeed, future proteomic studies of FoxO1 might help to decipher how its activity can be differentially regulated between acute and chronic infection and the types of cofactors it interacts with in T cells. Additionally, our study has provided proof of concept that manipulation of FoxO1, and possibly other members of the PI3K, AKT, and mTOR pathway, can regulate the expression and function of PD-1 in exhausted CTLs that could lead to therapeutic options for fighting chronic viral infection or cancer. However, our data would argue that fine-tuning of FoxO1 activities and/or temporal regulation thereof, as opposed to their complete blockade, might serve as more rational therapeutic design.
EXPERIMENTAL PROCEDURES
Mice and LCMV Infections C57BL/6j mice from NCI and Thy-1.1 + P14 TCR transgenic mice (Pircher et al., 1989 ) that recognize the H-2D b gp33 epitope were used where indicated. Clone 13 (Cl13)-which causes a chronic infection. Viral titers were determined by plaque assays as previously described (Cui et al., 2011) . The use of all animals was conducted in accordance with Yale University IACUC guidelines.
Flow Cytometry, Amnis, and Phospho-flow Cells were surface or intracellular stained with commercially available antibodies and kits from eBioscience or BD Biosciences. Importantly, for all signaling experiments, cells were rested for a period of 2-4 hr at 37 C in 1% RPMI medium to allow for any signals to return to background prior to peptide, a-CD3, or cytokine restimulation. 
Chromatin Immunoprecipitation
In brief, 10 3 10 6 cells were crosslinked with 1% formaldehyde and quenched with 0.125 M glycine as previously described (Ouyang et al., 2012) . Nuclei were isolated with 0.1% Triton buffer and sonicated in SDS lysis buffer to 300-500 bp size. A total of 5 mg of antibody was complexed overnight to anti-rabbit magnetic beads (Invitrogen), and 100 mg of chromatin was used per immunoprecipitation (IP) reaction. FoxO1 ChIP antibody (ab39670) was obtained from Abcam. Control rabbit-IgG was obtained from Santa Cruz Biotechnology. Samples were washed with low-salt, high-salt, LiCl, and TE buffers, eluted with SDS and reverse crosslinked overnight, followed by proteinase K digestion and DNA purification. Samples were then subjected to quantitative PCR with published primer sets (Oestreich et al., 2008) . A region outside of the promoter region (X-region) was used as a negative control (forward, 5 0 -CAGTATGCAGCTCCTGTCTCC-3 0 ; reverse, 5 0 -ACA CCATGACCAAACCCAAG-3 0 ), and FoxO1 KO P14 CTLs were used to control for antibody-IP specificity. Fold enrichment was calculated over rabbit IgG control.
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Retroviral Transduction P14 TCR transgenic mice were superinfected i.v. with 2 3 10 6 p.f.u. of LCMVArm. After 24 hr, P14 T cells were spin-transduced with MigR1-EV GFP or MigR1-FoxO1 AAA GFP retrovirus (a kind gift from T. Unterman, University of Illinois at Chicago) and a small number (1-5 3 10 3 ) of cells were adoptively transferred into LCMV-Cl13-infected recipients (Hand et al., 2010; Kao et al., 2011) .
Luciferase Reporter Assays
In brief, Jurkat T cells were cotransfected with firefly luciferase plasmids containing either the Pdcd1 promoter B-region or B+C region (a kind gift from J. Boss, Emory University) and a control Renilla luciferase plasmid via Fugene 6 transfection reagent (Promega). Cells were either left unstimulated or stimulated for 18 hr with PMA plus ionomycin to activate PD-1 luciferase reporter activity as previously reported (Oestreich et al., 2008) . Luciferase activity was determined by DualGlo Luciferase reagent (Promega). ''Fold over control'' Pdcd1 promoter luciferase activity was determined by normalizing to Renilla luciferase activity of stimulated over unstimulated samples.
Seahorse Extracelluar Flux Analysis
Seahorse analysis experiments were performed as previously described (Henao-Mejia et al., 2013) . In brief, day 8 P14 CTLs (Thy1.1 + ) were purified from LCMV-Arm-or LCMV-Cl13-infected mice by positive selection with magnetic bead (Stem Cell Technologies) to greater than 90% purity, and plated on a pretreated poly-D-lysine-coated 96-well polystyrene Seahorse plate. Cells were allowed to equilibrate at 37 C for 30 min prior to starting the assay. Oligomycin (ATPase inhibitor, 0.5 mM) and FCCP (0.2 mM) were injected where indicated and ECAR (mpH/min) oxygen consumption rate (pMoles/min) was measured.
Statistical Analysis
Data were analyzed by the Student's unpaired t test or with one-way ANOVA analysis with Tukey post-test for multiple comparisons with Prism 6. Error bars are the mean ± SEM. An asterisk indicating a p value of less than 0.05 (*p < 0.05) is considered significant. 
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